References
- Sawada T, Sugimoto T, Kawakatsu H, Matsumura T, Matsuda Y. Mass screening for neuroblastoma in Japan. Ped Hematol Oncol 1991; 8: 93–109
- Parker L, Craft A W, Dale G, Bell S, Cole M, McGill A C, Seviour J, Smith J. Screening for neuroblastoma in the north of England. Br Med J 1992; 305: 1260–1263
- Bell S, Parker L, Craft A W, Dale G, McGill A C, Seviour J, Cole M, Smith J. False-positive results in a neuroblastoma screening programme, In press
- Prorok P C. Epidemiologic approach for cancer screening. Problems in design and analysis of trials. Am J Ped Hematol Oncol 1992; 14: 117–128
- Love R R, Camilli A E. The value of screening. Cancer 1981; 48: 489–494
- Hogbin B, Fallowfield L. Getting it taped: the “bad news” consultation with cancer patients. Br J Hosp Med 1989; 41: 330–333
- Eden O B, Black I. Do taped parental interviews improve communication?. Abstract presented to the United Kingdom Children's Cancer Study Group; Annual Scientific Meeting, Newcastle upon Tyne. 11 November, 1992
- Mant D, Fitzpatrick R, Hogg A, Fuller A, Farmer A, Verne J, Northover J. Experiences of patients with false positive results from colorectal cancer screening. Br J Gen Practice 1990; 40: 423–425
- Bodegard G, Fyro K, Larsson A. Psychological reactions in 102 families with a newborn who has a falsely positive screening test for congenital hypothyroidism. Acta Paed Scad Supp 1983; 304: 1–21
- Ellman R, Angeli N, Christians A, Moss S, Chamberlain J, Maguire P. Psychiatric morbidity associated with screening for breast cancer. Br J Cancer 1989; 60: 781–784
- Bergman A B, Stamm S J. The morbidity of cardiac nondisease in schoolchildren. N Engl J Med 1967; 276: 1008–1013